Company / Inventory
Johnson & Johnson Inventory History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Inventory
$14.2B
FY2025
5-year range
$10.3B / $14.2B
FY2021-FY2025
Trend
+14.0%
vs FY2024
Sector context
#1 of 105
Health Care
What the data says
Among 105 Health Care companies, Johnson & Johnson is in the top 1% for inventory. Inventory has increased for 3 consecutive years, from $10.3B in FY2022 to $14.2B in FY2025.
Based on SEC 10-K filings.
$14.2B in FY2025 with a 5-year CAGR of +8.7%. Ranks 1st among 105 companies in Health Care.
Improved from $11.2B to $14.2B over the past 2 years.
Health Care sector context is included.
Inventory over time
Growth rates
- 3-Year CAGR
- +11.4%
- 5-Year CAGR
- +8.7%
- 10-Year CAGR
- -
Sector benchmark
Top 1% in Health CareTop 1% of 105This company $14.2B Sector average $885.3M
▼
+1503.0% above sector average
Key checks
Key Insights
- Johnson & Johnson's inventory has grown for 3 consecutive years.
- 5-year CAGR of +8.7%, indicating consistent growth.
- In FY2025, inventory increased 14.0% year-over-year.
- Ranks #1 out of 105 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 27.3%
- Strong return on equity: 31.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | InventoryValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $14.2B | +14.0% |
| FY2024 | $12.4B | +11.3% |
| FY2023 | $11.2B | +8.9% |
| FY2022 | $10.3B | -1.1% |
| FY2021 | $10.4B | +11.2% |
| FY2020 | $9.3B | +3.6% |
| FY2019 | $9.0B | +4.9% |
| FY2018 | $8.6B | -1.9% |
| FY2017 | $8.8B | +7.6% |
| FY2016 | $8.1B | +1.1% |
As of FY2025 · SEC 10-K · Updated Mar 11, 2026